Latest Chinese Drug Coverage Comes With Steep Price Cuts, Caveats

But Bigger Volumes Await

 
• By Dexter Jie Yan

November negotiations in China over the prices of 67 new drugs have resulted in record price cuts, averaging around 62% overall and 65% for anti-tumor products. But the sting is alleviated by the prospect of substantial volume increases.

Chines biotechs have won wider market access with reimbursement coverage in China.
reimbursement coverage gives Chinese biotechs wider market access - at a cost • Source: Alamy

More from China

More from Focus On Asia